Oxidative stress indicators are elevated in de novo Parkinson's disease patients

Functional Neurology

Volumn 14, Issue 3, 1999, Pages 141-147

  Ilic, Tihomir V ^a   Jovanovic, Marina ^b   Jovicic, Aco ^a   Tomovic, Mirjana ^a  

^a UNIVERSITY OF DEFENCE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Cerebrospinal fluid; Etiology; Free radicals; Oxidative stress; Parkinson's disease; Peripheral blood

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; FREE RADICAL; GLUTATHIONE REDUCTASE; MALONALDEHYDE;

ADULT; AGED; ARTICLE; BLOOD; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; PARKINSON DISEASE;

EID: 0032786731     PISSN: 03935264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Schapira AHV, Mann VM, Cooper JM. Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J Neurochem 1990; 55:2142-2145
2. Parker WD, Boyson SJ, Parks JK. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol 1989;26:719-723
3. Riederer P, Sofic E, Rausch W. Transition metals, ferritin, glutathione and ascorbic acid in parkinsonian brains. J Neurochem 1989; 52: 515-520
4. Dexter DT, Carayon A, Javoy-Agid F, Agid Y. Alterations in the levels of iron, ferritin, and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 1991;114: 1953-1975
5. Dexter DT, Carter CJ, Wells FR et al. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 1989;52:381-389
6. Snyder SH, D'Amato R. MPTP: A neurotoxin relevant to the pathophysiology of Parkinson's disease. Neurology 1986;36: 250-258
7. Jovanovic M, Jovicic A, Ivanovic L, Cernak I, Mrsulja BB. Free radicals in MPTP-induced parkinsonism. Iugosl Physiol Pharmacol Acta 1994,30;197-203
8. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442
9. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184
10. Andreeva JL, Kozemjakin AL, Kiskun AA. Modifikacija metoda opredelenija perekisej lipidov v teste s tiobarbiturovoj kislotoi. Lab Delo 1988;11:41-43
11. Auclair C, Voisin E. Nitroblue tetrazolium reduction. In: Greenwald RA ed Handbook of Methods for Oxygen Radical Research. Boca Raton; CRC Press Inc 1985: 123-132
12. Lowry OH, Passonneau JV eds A Flexible System of Enzymatic Analysis. New York; Academic Press 1974
13. Sun M, Zigman S. An improved spectrophotometric assay for superoxide dismutase based on epinephrine autooxidation. Analytical Biochemistry, 1978;90:81-89
14. SPSS. Statistical Package for the Social Sciences. Windows version, release 5.0. Chicago, III: SPSS Inc 1992
15. Gatto EM, Carreras MC, Pargament GA et al. Neutrophil function, nitric oxide, and blood oxidative stress in Parkinson's disease. Mov Disord 1996;11:261-267.
16. Fahn S, Cohen G. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann Neurol 1992:32;804-812.
17. Ben-Schachar D, Riederer P, Youdim MB. Iron-melanin interaction and lipid peroxidation: Implication for Parkinson's disease. J Neurochem 1991;57:1609-1614
18. Swerdlow RH, Parks JK, Miller SW, Tuttle JB, Trimmer PA, Sheehan JP. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann Neurol 1996;40:663-671
19. Olanow CW. An introduction to the free radical hypothesis in Parkinson's disease. Ann Neurol 1992;32:S2-S9
20. Jesberger JA, Richardson JS. Oxygen free radicals and brain dysfunction. Int J Neurosci 1991;57:1-17
21. Jovicic A, Ivanisevic V, Markovic M, Simovie M. Uloga azotnog oksida u fizioloskim funkcijama i patoloskim stanjima (The role of nitric oxide in physiological functions and pathological conditions). Vojnosanit Pregl 1994;51:126-131
22. Saggu H, Cooksey J, Dexter DT. A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J Neurochem 1989;53:692-697
23. Jenner P, Dexter DT, Sian J, Schapira AV, Marsden CD. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. Ann Neurol 1992;32:S82-S87
24. Perry TL, Yong VW. Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci Lett 1986;67:269-274
25. Kish SJ, Morito C, Hornykiewicz O. Glutathione peroxidase activity in Parkinson's disease. Neurosci Lett 1985;58:343-346